Influenza virus

Last updated: February 23, 2023

Influenza virus

5600

5600

Anatomy of the larynx and trachea
Bones and joints of the thoracic wall
Vessels and nerves of the thoracic wall
Anatomy of the lungs and tracheobronchial tree
Muscles of the thoracic wall
Anatomy of the pleura
Development of the respiratory system
Nasal cavity and larynx histology
Bronchioles and alveoli histology
Trachea and bronchi histology
Respiratory system anatomy and physiology
Ventilation-perfusion ratios and V/Q mismatch
Ventilation
Alveolar surface tension and surfactant
Upper respiratory tract infection
Sinusitis
Retropharyngeal and peritonsillar abscesses
Laryngitis
Bacterial epiglottitis
Anatomy of the pharynx and esophagus
Anatomy of the superior mediastinum
Anatomy of the inferior mediastinum
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Airflow, pressure, and resistance
Breathing cycle and regulation
Lung volumes and capacities
Pulmonary edema
Anatomic and physiologic dead space
Pulmonary shunts
Diffusion-limited and perfusion-limited gas exchange
Alveolar gas equation
Gas exchange in the lungs, blood and tissues
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Pleura and lungs
Otitis media
Eustachian tube dysfunction
Corynebacterium diphtheriae (Diphtheria)
Haemophilus influenzae
Bacterial tracheitis
Pediatric upper airway conditions: Clinical
Rhinovirus
Adenovirus
Moraxella catarrhalis
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Human parainfluenza viruses
Epstein-Barr virus (Infectious mononucleosis)
Influenza virus
Pediatric ear, nose, and throat conditions: Clinical
Alpha 1-antitrypsin deficiency
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Breathing cycle
Allergic rhinitis
Nasopharyngeal carcinoma
Oral cancer
Nasal polyps
Warthin tumor
Sjogren syndrome
Nasal, oral and pharyngeal diseases: Pathology review
Choanal atresia
Sialadenitis
Aphthous ulcers
Sleep apnea
Thoracic outlet syndrome
Neonatal respiratory distress syndrome
Cystic fibrosis
Cystic fibrosis: Clinical
Cystic fibrosis: Pathology review
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Idiopathic pulmonary fibrosis
Sarcoidosis
Hypersensitivity pneumonitis
Obstructive lung diseases: Pathology review
Chronic bronchitis
Emphysema
Asthma
Asthma: Clinical
Bronchiectasis
Type I hypersensitivity
Pharmacodynamics: Desensitization and tolerance
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical
Mycoplasma pneumoniae
Pulmonary changes at high altitude and altitude sickness
Oxygen-hemoglobin dissociation curve
Bronchodilators: Leukotriene antagonists and methylxanthines
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Tuberculosis: Pathology review
Respiratory syncytial virus
Lung cancer
Lung cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Pancoast tumor
Horner syndrome
Superior vena cava syndrome
Chronic obstructive pulmonary disease (COPD): Clinical
Chlamydia pneumoniae
Coxiella burnetii (Q fever)
Klebsiella pneumoniae
Streptococcus pneumoniae
Pseudomonas aeruginosa
Chronic granulomatous disease
Bordetella pertussis (Whooping cough)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pleural effusion: Clinical
Pleural effusion
Pneumothorax: Clinical
Pneumothorax
Acute respiratory distress syndrome
Acute respiratory distress syndrome: Clinical
Pulmonary hypertension
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Pulmonary embolism
Pulmonary hypoplasia
Congenital diaphragmatic hernia
Mesothelioma
Respiratory distress syndrome: Pathology review
Pulmonary changes during exercise
Pulmonary chemoreceptors and mechanoreceptors
Pulmonary corticosteroids and mast cell inhibitors
Syncope: Clinical
Anatomy of the heart
Anatomy of the coronary circulation
ECG rate and rhythm
ECG normal sinus rhythm
ECG QRS transition
Cardiac conduction system
Normal heart sounds
Vasculitis: Clinical
Aortic aneurysms and dissections: Clinical
Vascular tumors
Aneurysms
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Raynaud phenomenon
Deep vein thrombosis
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombophlebitis
Lymphedema
Angiosarcomas
Cardiac and vascular tumors: Pathology review
Sturge-Weber syndrome
Vasculitis: Pathology review
Kawasaki disease
Kawasaki disease: Clinical
Mitral valve disease
Tricuspid valve disease
Aortic valve disease
Pulmonary valve disease
Introduction to the cardiovascular system
Development of the cardiovascular system
Fetal circulation
Cardiac muscle histology
Arteriole, venule and capillary histology
Artery and vein histology
Cardiovascular system anatomy and physiology
Coronary circulation
Lymphatic system anatomy and physiology
Blood pressure, blood flow, and resistance
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Resistance to blood flow
Control of blood flow circulation
Microcirculation and Starling forces
Measuring cardiac output (Fick principle)
Frank-Starling relationship
Stroke volume, ejection fraction, and cardiac output
Cardiac afterload
Cardiac preload
Law of Laplace
Cardiac contractility
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Pressure-volume loops
Cardiac work
Changes in pressure-volume loops
Abnormal heart sounds
Action potentials in myocytes
Excitability and refractory periods
Action potentials in pacemaker cells
Cardiac excitation-contraction coupling
Cardiac conduction velocity
ECG basics
ECG intervals
ECG axis
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Transposition of the great vessels
Tetralogy of Fallot
Persistent truncus arteriosus
Total anomalous pulmonary venous return
Hypoplastic left heart syndrome
Patent ductus arteriosus
Coarctation of the aorta
Ventricular septal defect
Atrial septal defect
Human herpesvirus 8 (Kaposi sarcoma)
Lymphangioma
Chronic venous insufficiency
Vasculitis
Behcet's disease
Aortic dissection
Marfan syndrome
Myocarditis
Endocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Cardiac tamponade
Arterial disease
Angina pectoris
Unstable angina
Myocardial infarction
Prinzmetal angina
Hypertension
Hypertensive emergency
Renal artery stenosis
Orthostatic hypotension
Hypotension
Atrial flutter
Atrial fibrillation
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Dyslipidemias: Pathology review
Hypertension: Pathology review
Endocarditis: Pathology review
Pericardial disease: Pathology review
Shock
Shock: Clinical
Shock: Pathology review
Premature atrial contraction
Wolff-Parkinson-White syndrome
Atrioventricular nodal reentrant tachycardia (AVNRT)
Ventricular tachycardia
Premature ventricular contraction
Ventricular fibrillation
Brugada syndrome
Long QT syndrome and Torsade de pointes
Atrioventricular block
Bundle branch block
Heart failure
Cor pulmonale
Heart failure: Clinical
Heart failure: Pathology review
Positive inotropic medications
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
cGMP mediated smooth muscle vasodilators
Adrenergic antagonists: Beta blockers
Calcium channel blockers
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Ventricular arrhythmias: Pathology review
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Cardiac tumors
Dressler syndrome
Familial hypercholesterolemia
Abetalipoproteinemia
Hypertriglyceridemia
Hyperlipidemia
Pheochromocytoma
Antihistamines for allergies
Mycobacterium avium complex (NORD)
Nocardia
Pneumocystis jirovecii (Pneumocystis pneumonia)
Cryptococcus neoformans
Coccidioidomycosis and paracoccidioidomycosis
Histoplasmosis
Blastomycosis
Aspergillus fumigatus

Transcript

Watch video only

Content Reviewers

Influenza, the virus that causes the flu, is one of the most common infectious diseases.

Now, there are three types of influenza that infect humans, called type A, type B, and type C, each one with slightly different genome and proteins.

Influenza belongs to the virus family Orthomyxoviridae - and type A and B have genomes that are made up of eight RNA segments, whereas type C, has a seven-segment RNA genome, with each segment containing a few genes.

Now, type A, the most common type of influenza virus, can be further subdivided based on two of the glycoproteins on its protective envelope surface; H protein, or Hemagglutinin, and N protein, or neuraminidase.

Hemagglutinin and Neuraminidase can vary a bit in their structure, so different versions are identified by a number.

For example, type A subtype H3N2, sometimes just called H3N2, has hemagglutinin number 3 and neuraminidase number 2 on its surface.

H3N2 and H1N1 are the most common type A subtypes to infect humans, but they both also infect various animals.

To give the full name of a virus, we use the type, the original host that it came from, the location where the virus was first identified, which is usually a city, the strain number, the year of origin, and—for type A influenza—the subtype named by the H and N glycoproteins.

For example, an H1N1 type A flu virus of duck origin from the province of Alberta, Canada, that is the 35th strain discovered in 1976 would be called A/duck/Alberta/35/76 (H1N1).

Type B influenza is less common, it only infects humans and doesn't mutate as often as type A.

Type B influenza only has a few types of H and N glycoproteins on its surface.

Therefore the naming pattern is similar to type A influenza without the H and N subtype included at the end or the host type, since it only infects humans.

For example, a type B virus found in Yamagata, Japan, which is the 16th strain discovered in 1988 would be called B/Yamagata/16/88.

Finally, there's type C influenza which is only one species, and is the least common and least likely to mutate of the three.

Influenza C usually causes mild disease in children, and unlike type B, it can affect both humans and pigs.

Rather than hemagglutinin and neuraminidase, type C influenza uses a hemagglutinin-esterase-fusion protein to enter and exit cells.

So, type C influenza is named without the HN subtype, similar to how type B's written.

For example, a type C virus found in Sao Paulo, Brazil which is the 37th strain discovered in 1982 would be called C/Sao Paulo/37/82.

Of the three types, type A is the most common and causes the most severe illness.

One reason is that the virus has a tendency to mutate its H and N glycoproteins during replication, and this allows daughter viruses to form that are slightly different from one another and from the parent virus.

Over time, if enough of these small changes happen, even if somebody's immune to the original virus, the mutated virus may have H and N glycoproteins that are different enough to allow it to evade antibodies, and therefore infect people who were immune to previous strains.

This process is called genetic drift, and is why individuals can get sick from influenza year after year or from two different strains of influenza in the same year.

In addition, a process called antigenic shift, is where sometimes a virus will be circulating among animal populations like pigs or chickens and then will suddenly change in a way that allows the virus to infect humans as well.

This happens when the same cell, let's say a pig cell, gets infected with two similar flu viruses, for example a flu strain that usually infects humans and one that usually infects pigs.

Since the viral genome is in segments of RNA, the pieces might reassort, or mix, allowing new viruses to have a mix of RNA segments in them.

Reassortment results in viruses that have entirely new hemagglutinin, neuraminidase, or both.

When a virus is produced that can infect human cells and has entirely new proteins, people have little or no protection against it, and it can rapidly spread through the population.

This antigenic shift process is responsible for three major influenza pandemics in the 20th century, including the Spanish Flu in 1918, which killed 3 percent of the world's entire population at the time.

The flu is transmitted when an infected person sneezes or coughs, which spreads thousands of droplets containing the virus into the local area, up to about two meters or six feet away.

These droplets can then land in the mouths or noses of people nearby, or get inhaled into the lungs.

The virus can also survive on surfaces for a few hours, so it's possible to get the virus by touching a surface, like a contaminated doorknob, and then touching your own eyes, nose, or mouth.

When the flu virus enters the body, it uses hemagglutinin to bind to sialic acid sugars on the surface of epithelial cells in the upper respiratory tract.

Once bound, the cell swallows up the virus in a process called endocytosis.

That viral RNA is negative-sense, meaning that each piece first has to be transcribed by RNA polymerase into positive-sense mRNA strands, before it can be translated into proteins and assembled into viruses.

These viruses leave the cell by simply budding out from it by using the neuraminidase, which cleaves the sialic acid sugars in the membrane, releasing the newly created viruses from the cell.

Influenza symptoms start 1-4 days after infection and include fever, headache, runny nose, sore throat, and a cough.

Most of these symptoms get better in a week, but the cough often persists for up to two weeks.

There can sometimes be complications, though, like acute otitis media, bronchiolitis, croup, sinusitis, and pneumonia, including antibiotic-resistant strains caused by Staphylococcus aureus and Streptococcus pneumoniae.

The highest risk of complications is among high-risk groups like young children under 6 months of age, pregnant women, adults over 65 years old, and those with chronic medical conditions, like chronic heart or lung disease.